Prognostic biomarkers in endometrial and ovarian carcinoma. - Test2 - elhamkhani - TriplyDB

Prognostic biomarkers in endometrial and ovarian carcinoma.

Prognostic biomarkers in endometrial and ovarian carcinoma.

http://www.wikidata.org/entity/Q38185940

about

Identification of two poorly prognosed ovarian carcinoma subtypes associated with CHEK2 germ-line mutation and non-CHEK2 somatic mutation gene signatures.Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma.Prognostic value of circulating tumor cells and disseminated tumor cells in patients with ovarian cancer: a systematic review and meta-analysis Molecular staging of gynecological cancer: What is the future?Mitochondrial ribosomal protein S18-2 is highly expressed in endometrial cancers along with free E2F1.The role of miRNAs in endometrial cancer.Frontline treatment of epithelial ovarian cancer.Clinical significance of Sam68 expression in endometrial carcinoma.The future role of molecular staging in gynecologic cancer.Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile.The Potential Roles of MELF-Pattern, Microvessel Density, and VEGF Expression in Survival of Patients with Endometrioid Endometrial Carcinoma: A Morphometrical and Immunohistochemical Analysis of 100 Cases.PAX8 is a potential marker for the diagnosis of primary epithelial ovarian cancer.Unsupervised Clustering of Immunohistochemical Markers to Define High-Risk Endometrial Cancer.Expression of P-REX2a is associated with poor prognosis in endometrial malignancies.

P2860

Q33952816-B2F47189-23B6-437D-8ECC-DE6C5F552539 Q34293217-98D7A0E7-54C6-486C-9B98-C1C8FEB2F3C9 Q35775519-ABAF5FFE-DF1C-4EE6-BA50-BAD2A0D60528 Q35940829-FDB50C3F-C12F-447E-B05F-A9ED3A0899B1 Q37225495-91C37E19-2136-4ABD-8A47-7CC38B18F3DA Q38600963-34858624-3E8F-4BD0-A35E-0D8C0AA60EEF Q38669746-FA560B4F-5538-4B12-B15C-302BF2B69579 Q38887139-6F9CD4D0-E3D2-46BA-84A9-AE9265E7BA96 Q38957038-29618EAF-157F-4BFF-8B0A-100C9B6D2BB3 Q40955139-3B17C1E7-4ECB-4820-AFB4-A2B18063E181 Q41686035-E2671D5C-BD7D-4F26-B7D7-044F37F22CAE Q47103850-7E2F0A0F-6CED-41F3-8B89-D04355B221FB Q47267493-0FCBF73A-004E-43A3-9E60-5F6FB3A22263 Q55196611-DDA992B4-63CE-4813-BC93-27C1E497327A

P2860

Prognostic biomarkers in endometrial and ovarian carcinoma.

http://www.wikidata.org/entity/Q38185940

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Prognostic biomarkers in endometrial and ovarian carcinoma.

@en

type

label

Prognostic biomarkers in endometrial and ovarian carcinoma.

@en

prefLabel

Prognostic biomarkers in endometrial and ovarian carcinoma.

@en

P1433

Q38185940-551C7A90-52D2-48CA-95F3-3F3FF1F20C6C

P1476

Q38185940-03C67951-64B6-4C07-801B-7F0C046E55CE

P2093

Q38185940-8D98896D-2AE5-41EC-B426-00581808563F

Q38185940-ABB558EF-B3CE-4282-9D21-1E78ECCAE21B

P2860

Q38185940-01750B80-9C60-4054-BAFA-2F4501300CB6

Q38185940-01D67504-AF23-417C-A8A1-2937F97FF572

Q38185940-08DF1999-0C21-4439-874B-36AADB547DA1

Q38185940-0C462450-15C8-4EBA-8318-551D62B44B29

Q38185940-0DAC2644-1019-4C96-B191-871EEAC58EC9

Q38185940-0DD83338-D582-4E4A-834F-7F1EB2543F81

Q38185940-0EB67BA1-D292-4698-BA99-53AB69AB067B

Q38185940-0EC44ABD-CB22-47ED-98C7-1C863832A1B2

Q38185940-0F462F03-A5B2-4BFB-AC87-FA59DEB112D7

Q38185940-13A4BE3B-AA4D-4389-B844-61D219AFA38B

P2888

Q38185940-CD4AFE1D-C72F-408D-8708-BDC5C4B61C76

P304

Q38185940-6DF943E8-E6AB-49DE-B4C6-0F114E320B24

P31

Q38185940-E53EE711-C29B-4993-96C0-52828475DE4D

P356

Q38185940-179FD03A-9173-4539-818E-5C93F84DD99A

P433

Q38185940-CB3573F3-3DC7-4F3C-983B-F91F43B1C3EA

P478

Q38185940-930B563D-F396-411F-87B1-CF0BE342FB7C

P577

Q38185940-6233901F-C175-40FB-B032-4EB9C3C02378

P698

Q38185940-C47A0B41-0866-4493-A48D-1EB87EAFE5A9

P921

Q38185940-015FE1B2-ADC2-4611-986E-6BF5D523D1A4

P356

S00428-013-1509-Y

P1433

Virchows Archiv

P1476

Prognostic biomarkers in endometrial and ovarian carcinoma.

@en

P2093

Ben Davidson

http://www.w3.org/2001/XMLSchema#string

Xavier Matias-Guiu

http://www.w3.org/2001/XMLSchema#string

P2860

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies

MicroRNA signatures differentiate uterine cancer tumor subtypes

BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer.

Integrated genomic analyses of ovarian carcinoma

Cancer statistics, 2012

Integrated genomic characterization of endometrial carcinoma

FGFR2 point mutations in 466 endometrioid endometrial tumors: relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and clinicopathological features

Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study

Interpretation of p53 immunoreactivity in endometrial carcinoma: establishing a clinically relevant cut-off level.

Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma.

P2888

s00428-013-1509-y

P304

315-331

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-013-1509-Y

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

464

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24504546

http://www.w3.org/2001/XMLSchema#string

P921